You are here

  • Home
  • Archive
  • Volume 71, Issue Suppl 3
  • THU0036 PPAR gamma agonist rosiglitazone could inhibit RA-FLS induced osteoclastogenesis by down-regulating RANKL expression and suppression of ERK phosphorylation

Citation Tools

Article menu
Download PDFPDF
Scientific Abstracts
Poster Presentations
Posters
Cartilage, synovium and osteoimmunology
THU0036 PPAR gamma agonist rosiglitazone could inhibit RA-FLS induced osteoclastogenesis by down-regulating RANKL expression and suppression of ERK phosphorylation

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Wei X, Dai L, Zhu L, et al
THU0036 PPAR gamma agonist rosiglitazone could inhibit RA-FLS induced osteoclastogenesis by down-regulating RANKL expression and suppression of ERK phosphorylation
Annals of the Rheumatic Diseases 2013;71:165.